The Clinimetric Spectrum of Poor Response After Treatment for Chronic Inflammatory Demyelinating Polyneuropathy

Stevie C. E. Rozing, Milou R. Michael, Ivo N. van Schaik, Pieter A. van Doorn, Ivana Basta, Stojan Peric, Michael P. Lunn, Laura Zambreanu, Robert D. M. Hadden, Luuk Wieske, Filip Eftimov
Muscle and Nerve · Wiley · 2026-11-18 · DOI: 10.1002/mus.70464

Abstract

ABSTRACT Introduction/Aims Clinicians regularly modify treatment in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) because of insufficient response, yet it is unclear how changes over time in the recommended outcome measures inform these decisions. We therefore explored which changes were observed in patients deemed to have an insufficient treatment response. Methods We selected patients with CIDP who were previously included in various prospective studies, in whom first‐line treatment was changed within 6 months due to deterioration or insufficient improvement. Changes in two disability and two impairment measures were analyzed according to commonly used minimal clinically important difference (MCID) thresholds. Results We included 16 patients. Median time to treatment change was 12 weeks (IQR 6 to 19). In seven patients (44%), treatment change coincided with deterioration on all available outcome measures, and this occurred within 12 weeks of treatment in 6 patients. Earlier change was associated with more severe baseline disability and impairment, and greater magnitude of deterioration. In seven patients (44%), treatment was changed despite (limited) improvement on one or two outcome measures; all of these observations occurred after 12 weeks. Discussion Earlier treatment change seemed to be associated with clear deterioration on most outcome measures, while later treatment changes were mainly associated with insufficient improvement, reflected by a combination of improvement and worsening in different clinical outcome measures. Our findings suggest that poor response to treatment requires a nuanced consideration of multiple outcome measures, taking the magnitude and consistency of change into account in relation to treatment duration.

Read at publisher →

Similar articles